The BBC brings you all the week's science news.
…
continue reading
Conteúdo fornecido por Research Round-up. Todo o conteúdo do podcast, incluindo episódios, gráficos e descrições de podcast, é carregado e fornecido diretamente por Research Round-up ou por seu parceiro de plataforma de podcast. Se você acredita que alguém está usando seu trabalho protegido por direitos autorais sem sua permissão, siga o processo descrito aqui https://pt.player.fm/legal.
Player FM - Aplicativo de podcast
Fique off-line com o app Player FM !
Fique off-line com o app Player FM !
December 2018 - Willie Hamilton and Jon Emery
MP3•Home de episódios
Manage episode 222554547 series 2446824
Conteúdo fornecido por Research Round-up. Todo o conteúdo do podcast, incluindo episódios, gráficos e descrições de podcast, é carregado e fornecido diretamente por Research Round-up ou por seu parceiro de plataforma de podcast. Se você acredita que alguém está usando seu trabalho protegido por direitos autorais sem sua permissão, siga o processo descrito aqui https://pt.player.fm/legal.
Professor Jon Emery talks with Professor Willie Hamilton, co-chair of CanTest and a GP and lead of the DISCOVERY group in Exeter, Willie is also clinical lead for the 2015 NICE guidance, as well as a member of the Department of Health’s Policy Research Unit for cancer awareness, screening and early diagnosis. Both are part of CanTest – a five year programme of funding from Cancer Research UK, where international primary care cancer researchers investigate ways of developing and implementing new and improved cancer diagnostic tests into GP surgeries. Professor Hamilton discusses recently published Early detection of multiple myeloma in primary care using blood tests: a case–control study in primary care. This UK based, matched case-control study examined the combined predictive value of presenting symptoms and blood tests commonly used in primary care in order to find which are useful in suggesting/excluding a diagnosis of multiple myeloma. Using data from over 2,700 cases and more than 12,000 controls, the study found that plasma viscosity (PV) and ESR were better than C-reactive protein for ruling in/out myeloma. Show notes available here http://pc4tg.com.au/research-round-up-december-2018-willie-hamilton/
…
continue reading
49 episódios
MP3•Home de episódios
Manage episode 222554547 series 2446824
Conteúdo fornecido por Research Round-up. Todo o conteúdo do podcast, incluindo episódios, gráficos e descrições de podcast, é carregado e fornecido diretamente por Research Round-up ou por seu parceiro de plataforma de podcast. Se você acredita que alguém está usando seu trabalho protegido por direitos autorais sem sua permissão, siga o processo descrito aqui https://pt.player.fm/legal.
Professor Jon Emery talks with Professor Willie Hamilton, co-chair of CanTest and a GP and lead of the DISCOVERY group in Exeter, Willie is also clinical lead for the 2015 NICE guidance, as well as a member of the Department of Health’s Policy Research Unit for cancer awareness, screening and early diagnosis. Both are part of CanTest – a five year programme of funding from Cancer Research UK, where international primary care cancer researchers investigate ways of developing and implementing new and improved cancer diagnostic tests into GP surgeries. Professor Hamilton discusses recently published Early detection of multiple myeloma in primary care using blood tests: a case–control study in primary care. This UK based, matched case-control study examined the combined predictive value of presenting symptoms and blood tests commonly used in primary care in order to find which are useful in suggesting/excluding a diagnosis of multiple myeloma. Using data from over 2,700 cases and more than 12,000 controls, the study found that plasma viscosity (PV) and ESR were better than C-reactive protein for ruling in/out myeloma. Show notes available here http://pc4tg.com.au/research-round-up-december-2018-willie-hamilton/
…
continue reading
49 episódios
Todos os episódios
×Bem vindo ao Player FM!
O Player FM procura na web por podcasts de alta qualidade para você curtir agora mesmo. É o melhor app de podcast e funciona no Android, iPhone e web. Inscreva-se para sincronizar as assinaturas entre os dispositivos.